Featured Research

from universities, journals, and other organizations

Vaccination Halts Progression Of Atherosclerosis In Animal Studies, UCSD Researchers Report

Date:
May 13, 2003
Source:
University Of California - San Diego
Summary:
Researchers at the University of California, San Diego (UCSD) School of Medicine have shown in mice that a vaccine for pneumonia also triggers elements of the immune system to reduce atherosclerosis, the build-up of fatty deposits and chronic inflammation in blood vessels, which leads to heart attacks and stroke.

Researchers at the University of California, San Diego (UCSD) School of Medicine have shown in mice that a vaccine for pneumonia also triggers elements of the immune system to reduce atherosclerosis, the build-up of fatty deposits and chronic inflammation in blood vessels, which leads to heart attacks and stroke.

While pneumococcal vaccination is known to build the body's defenses against bacterial pneumonia, this is the first demonstration that a pneumococcal vaccine can also protect the host from a chronic inflammatory disease process such as atherosclerosis.

In a study published in the June 2003 issue of the journal Nature Medicine, the researchers demonstrate that vaccination with pneumococci microbes, and the resulting immune response triggered by the body, reduced the extent of atherosclerosis by 21 percent in laboratory mice that are used as a model for coronary disease.

A complex disease with multiple causes, atherosclerosis has traditionally been considered a disorder caused by excess levels of cholesterol in the body. More recently, scientists have identified the chronic inflammatory process of the disease, with recent studies suggesting that the body's natural immune responses might be able to modulate the progression of atherosclerosis.

The study's first author, Christoph J. Binder, M.D., Ph.D., a post-doctoral researcher in the lab of co-senior author Joseph Witztum, M.D., said "the test of pneumococcal vaccination grew from the team's study of immune responses against oxidized low-density lipoproteins (LDL), the 'bad' cholesterol that leads to plaque build-up in arteries."

For the past 20 years, the Witztum lab at UCSD, in collaboration with UCSD professor of medicine Daniel Steinberg, M.D., Ph.D., has pioneered the role of oxidized LDL as a major contributing factor for the development of atherosclerosis. In particular, the Witztum lab has been studying immunological response to oxidized LDL and its impact on development and modulation of atherosclerosis.

Once LDL becomes oxidized, it undergoes structural changes in such a way that it is recognized by the host's immune system. Macrophages, scavenger cells that have been drawn to the site, engulf the oxidized LDL and become "foam cells," the hallmark of atherosclerotic plaques.

In the current study, the scientists discovered that a chemical structure called phosphorylcholine on the surface of oxidized LDL was identical to a molecular site on S. pneumoniae, the major cause of bacterial pneumonia. In turn, a natural antibody, IgM, reacted with both pneumococcal bacteria and oxidized LDL by binding to that chemical structure. Based on these observations, the scientists tested vaccination with pneumococci in laboratory mice and determined that the resulting immune response arrested the progression of atherosclerosis.

"We've established that IgM antibodies specific for oxidized LDL have a protective role in atherosclerosis," said Witztum, a UCSD professor of medicine. "This provides insight into the biological role of these immune responses and is an important basis for the development of therapeutic interventions."

Co-senior author Gregg Silverman, M.D., UCSD professor of medicine, added that "researchers have used this same bacterial immunization for decades to study an antibody response important for defense from infection. No one previously suspected that there might be relevance to other types of diseases, especially a disease like atherosclerosis."

"Our next step will be to identify and better characterize the equivalent immune responses in humans, with the hope of eventually designing a vaccine specific to atherosclerosis," Witztum said.

The study was supported by the Specialized Center of Research in Molecular Medicine and Atherosclerosis at the National Institutes of Health.

Sohvi Hörkkö, M.D., Ph.D., University of Oulu, Finland, and Asheesh Dewan, M.D., UCSD Division of Endocrinology & Metabolism, were equal contributors to this study, as was co-senior author Wulf Palinski, M.D., UCSD professor of medicine. Additional authors were Mi-Kyung Chang, M.D., Emily P. Kieu, Carl S. Goodyear, Ph.D., UCSD Division of Rheumatology, Allergy and Immunology; and Peter S. Shaw, Ph.D., UCSD Division of Endocrinology & Metabolism.


Story Source:

The above story is based on materials provided by University Of California - San Diego. Note: Materials may be edited for content and length.


Cite This Page:

University Of California - San Diego. "Vaccination Halts Progression Of Atherosclerosis In Animal Studies, UCSD Researchers Report." ScienceDaily. ScienceDaily, 13 May 2003. <www.sciencedaily.com/releases/2003/05/030513075735.htm>.
University Of California - San Diego. (2003, May 13). Vaccination Halts Progression Of Atherosclerosis In Animal Studies, UCSD Researchers Report. ScienceDaily. Retrieved September 19, 2014 from www.sciencedaily.com/releases/2003/05/030513075735.htm
University Of California - San Diego. "Vaccination Halts Progression Of Atherosclerosis In Animal Studies, UCSD Researchers Report." ScienceDaily. www.sciencedaily.com/releases/2003/05/030513075735.htm (accessed September 19, 2014).

Share This



More Health & Medicine News

Friday, September 19, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) — The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) — A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com
How The 'Angelina Jolie Effect' Increased Cancer Screenings

How The 'Angelina Jolie Effect' Increased Cancer Screenings

Newsy (Sep. 19, 2014) — Angelina's Jolie's decision to undergo a preventative mastectomy in 2013 inspired many women to seek early screenings for the disease. Video provided by Newsy
Powered by NewsLook.com
The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) — As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins